Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Price:
31.52
CNY
2.47%
Market Closed
Market Cap:
24.3B
CNY
Income Statement
Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
|
Revenue
|
8B
CNY
|
|
Cost of Revenue
|
-4.4B
CNY
|
|
Gross Profit
|
3.7B
CNY
|
|
Operating Expenses
|
-2.9B
CNY
|
|
Operating Income
|
793.6m
CNY
|
|
Other Expenses
|
138.7m
CNY
|
|
Net Income
|
932.4m
CNY
|
Income Statement
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Currency: CNY
Millions
TTM
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
6 621
N/A
|
7 087
+7%
|
7 156
+1%
|
7 114
-1%
|
7 026
-1%
|
7 081
+1%
|
7 104
+0%
|
6 997
-2%
|
6 845
-2%
|
6 243
-9%
|
6 081
-3%
|
5 952
-2%
|
5 747
-3%
|
5 689
-1%
|
5 823
+2%
|
5 814
0%
|
6 085
+5%
|
6 359
+5%
|
6 497
+2%
|
6 780
+4%
|
6 847
+1%
|
6 994
+2%
|
6 897
-1%
|
6 751
-2%
|
6 774
+0%
|
6 604
-3%
|
6 775
+3%
|
6 954
+3%
|
6 999
+1%
|
6 908
-1%
|
6 970
+1%
|
7 042
+1%
|
7 118
+1%
|
8 249
+16%
|
8 514
+3%
|
8 563
+1%
|
8 479
-1%
|
8 222
-3%
|
8 153
-1%
|
8 099
-1%
|
8 040
-1%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(4 622)
|
(4 941)
|
(5 012)
|
(4 963)
|
(4 908)
|
(4 993)
|
(5 097)
|
(5 080)
|
(4 882)
|
(4 228)
|
(4 074)
|
(3 911)
|
(3 685)
|
(3 489)
|
(3 533)
|
(3 405)
|
(3 563)
|
(3 739)
|
(3 878)
|
(4 051)
|
(4 046)
|
(4 073)
|
(4 104)
|
(4 015)
|
(4 140)
|
(4 024)
|
(4 170)
|
(4 280)
|
(4 214)
|
(4 161)
|
(4 304)
|
(4 338)
|
(4 399)
|
(4 992)
|
(4 994)
|
(4 987)
|
(4 945)
|
(4 632)
|
(4 592)
|
(4 499)
|
(4 358)
|
|
| Gross Profit |
1 999
N/A
|
2 146
+7%
|
2 144
0%
|
2 150
+0%
|
2 118
-1%
|
2 088
-1%
|
2 007
-4%
|
1 917
-4%
|
1 963
+2%
|
2 015
+3%
|
2 006
0%
|
2 041
+2%
|
2 062
+1%
|
2 201
+7%
|
2 289
+4%
|
2 409
+5%
|
2 522
+5%
|
2 620
+4%
|
2 619
0%
|
2 730
+4%
|
2 802
+3%
|
2 921
+4%
|
2 793
-4%
|
2 736
-2%
|
2 634
-4%
|
2 580
-2%
|
2 605
+1%
|
2 674
+3%
|
2 785
+4%
|
2 747
-1%
|
2 666
-3%
|
2 703
+1%
|
2 719
+1%
|
3 257
+20%
|
3 520
+8%
|
3 576
+2%
|
3 535
-1%
|
3 590
+2%
|
3 562
-1%
|
3 599
+1%
|
3 682
+2%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 626)
|
(1 773)
|
(1 769)
|
(1 760)
|
(1 745)
|
(1 694)
|
(1 631)
|
(1 577)
|
(1 607)
|
(1 719)
|
(1 736)
|
(1 784)
|
(1 772)
|
(1 852)
|
(1 923)
|
(2 022)
|
(2 102)
|
(2 152)
|
(2 128)
|
(2 217)
|
(2 288)
|
(2 384)
|
(2 254)
|
(2 190)
|
(2 055)
|
(1 993)
|
(1 970)
|
(1 977)
|
(2 059)
|
(2 154)
|
(2 076)
|
(2 079)
|
(2 072)
|
(2 576)
|
(2 679)
|
(2 738)
|
(2 753)
|
(2 775)
|
(2 774)
|
(2 806)
|
(2 889)
|
|
| Selling, General & Administrative |
(1 638)
|
(1 511)
|
(1 760)
|
(1 750)
|
(1 733)
|
(1 510)
|
(1 601)
|
(1 544)
|
(1 572)
|
(1 633)
|
(1 682)
|
(1 707)
|
(1 702)
|
(1 741)
|
(1 873)
|
(1 946)
|
(2 030)
|
(2 002)
|
(1 989)
|
(2 099)
|
(2 155)
|
(2 193)
|
(2 126)
|
(2 055)
|
(1 934)
|
(1 830)
|
(1 846)
|
(1 845)
|
(1 914)
|
(1 948)
|
(1 931)
|
(1 929)
|
(1 912)
|
(2 373)
|
(2 483)
|
(2 546)
|
(2 555)
|
(2 561)
|
(2 537)
|
(2 575)
|
(2 655)
|
|
| Research & Development |
0
|
(71)
|
0
|
0
|
0
|
(73)
|
0
|
0
|
0
|
(68)
|
0
|
(30)
|
(44)
|
(79)
|
0
|
(52)
|
(55)
|
(96)
|
(121)
|
(118)
|
(126)
|
(125)
|
(133)
|
(126)
|
(128)
|
(139)
|
(158)
|
(169)
|
(168)
|
(150)
|
(151)
|
(150)
|
(159)
|
(144)
|
(158)
|
(150)
|
(147)
|
(175)
|
(185)
|
(179)
|
(197)
|
|
| Depreciation & Amortization |
0
|
(183)
|
0
|
0
|
0
|
(106)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
0
|
(74)
|
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(64)
|
0
|
0
|
0
|
(61)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
13
|
(8)
|
(9)
|
(10)
|
(12)
|
(6)
|
(30)
|
(33)
|
(35)
|
35
|
(54)
|
(48)
|
(27)
|
25
|
(50)
|
(25)
|
(18)
|
6
|
(17)
|
0
|
(7)
|
9
|
5
|
(10)
|
7
|
40
|
34
|
37
|
23
|
8
|
7
|
0
|
(1)
|
3
|
(37)
|
(42)
|
(50)
|
20
|
(51)
|
(51)
|
(37)
|
|
| Operating Income |
374
N/A
|
373
0%
|
375
+1%
|
390
+4%
|
373
-4%
|
393
+5%
|
376
-4%
|
340
-10%
|
356
+5%
|
296
-17%
|
270
-9%
|
257
-5%
|
290
+13%
|
348
+20%
|
366
+5%
|
387
+5%
|
420
+9%
|
468
+11%
|
491
+5%
|
513
+4%
|
514
+0%
|
537
+4%
|
538
+0%
|
545
+1%
|
578
+6%
|
588
+2%
|
634
+8%
|
696
+10%
|
726
+4%
|
593
-18%
|
590
0%
|
624
+6%
|
647
+4%
|
681
+5%
|
841
+24%
|
838
0%
|
782
-7%
|
815
+4%
|
788
-3%
|
794
+1%
|
794
0%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
74
|
41
|
57
|
40
|
92
|
30
|
109
|
169
|
138
|
123
|
165
|
193
|
183
|
139
|
208
|
182
|
160
|
168
|
147
|
150
|
189
|
192
|
198
|
203
|
207
|
190
|
190
|
212
|
219
|
262
|
262
|
258
|
313
|
246
|
359
|
398
|
308
|
326
|
295
|
242
|
261
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
76
|
0
|
(0)
|
0
|
19
|
20
|
20
|
0
|
37
|
0
|
4
|
5
|
5
|
23
|
21
|
30
|
30
|
0
|
14
|
0
|
8
|
13
|
14
|
15
|
12
|
0
|
0
|
0
|
53
|
1
|
1
|
1
|
(44)
|
(0)
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
(2)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
10
|
18
|
19
|
41
|
42
|
39
|
42
|
29
|
31
|
29
|
28
|
17
|
12
|
7
|
4
|
3
|
4
|
1
|
(1)
|
(2)
|
(9)
|
(15)
|
(14)
|
(31)
|
(25)
|
(16)
|
(18)
|
4
|
7
|
8
|
5
|
0
|
(4)
|
1
|
0
|
1
|
2
|
(1)
|
(2)
|
(2)
|
3
|
|
| Pre-Tax Income |
456
N/A
|
431
-5%
|
450
+4%
|
470
+5%
|
506
+8%
|
537
+6%
|
526
-2%
|
536
+2%
|
523
-2%
|
466
-11%
|
482
+3%
|
487
+1%
|
486
0%
|
531
+9%
|
579
+9%
|
576
-1%
|
589
+2%
|
641
+9%
|
659
+3%
|
681
+3%
|
723
+6%
|
743
+3%
|
722
-3%
|
730
+1%
|
761
+4%
|
768
+1%
|
820
+7%
|
926
+13%
|
968
+5%
|
873
-10%
|
857
-2%
|
883
+3%
|
957
+8%
|
980
+2%
|
1 202
+23%
|
1 239
+3%
|
1 094
-12%
|
1 095
+0%
|
1 081
-1%
|
1 034
-4%
|
1 057
+2%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(65)
|
(51)
|
(54)
|
(58)
|
(63)
|
(79)
|
(78)
|
(71)
|
(63)
|
(58)
|
(56)
|
(53)
|
(59)
|
(58)
|
(65)
|
(63)
|
(71)
|
(73)
|
(74)
|
(75)
|
(105)
|
(108)
|
(104)
|
(114)
|
(85)
|
(88)
|
(98)
|
(107)
|
(104)
|
(86)
|
(85)
|
(91)
|
(101)
|
(107)
|
(133)
|
(129)
|
(124)
|
(127)
|
(127)
|
(129)
|
(138)
|
|
| Income from Continuing Operations |
391
|
379
|
396
|
412
|
443
|
458
|
448
|
465
|
461
|
409
|
427
|
434
|
427
|
473
|
514
|
513
|
518
|
568
|
585
|
606
|
618
|
635
|
618
|
615
|
675
|
680
|
722
|
818
|
863
|
787
|
772
|
792
|
856
|
873
|
1 069
|
1 110
|
969
|
969
|
954
|
905
|
920
|
|
| Income to Minority Interest |
(19)
|
(22)
|
(21)
|
(14)
|
(7)
|
(6)
|
4
|
6
|
6
|
15
|
11
|
8
|
6
|
3
|
2
|
(1)
|
(1)
|
(6)
|
(7)
|
(11)
|
(12)
|
(10)
|
(13)
|
(13)
|
(18)
|
(18)
|
(17)
|
(18)
|
(17)
|
(18)
|
(17)
|
(17)
|
(19)
|
(11)
|
(6)
|
6
|
22
|
18
|
19
|
17
|
13
|
|
| Net Income (Common) |
372
N/A
|
358
-4%
|
375
+5%
|
398
+6%
|
436
+9%
|
451
+4%
|
452
+0%
|
471
+4%
|
467
-1%
|
424
-9%
|
438
+3%
|
443
+1%
|
433
-2%
|
476
+10%
|
516
+8%
|
512
-1%
|
518
+1%
|
562
+9%
|
578
+3%
|
595
+3%
|
606
+2%
|
626
+3%
|
606
-3%
|
602
-1%
|
657
+9%
|
662
+1%
|
705
+6%
|
801
+14%
|
846
+6%
|
769
-9%
|
756
-2%
|
775
+3%
|
837
+8%
|
862
+3%
|
1 063
+23%
|
1 116
+5%
|
991
-11%
|
987
0%
|
973
-1%
|
922
-5%
|
932
+1%
|
|
| EPS (Diluted) |
0.51
N/A
|
0.48
-6%
|
0.51
+6%
|
0.54
+6%
|
0.56
+4%
|
0.59
+5%
|
0.6
+2%
|
0.62
+3%
|
0.61
-2%
|
0.55
-10%
|
0.57
+4%
|
0.58
+2%
|
0.57
-2%
|
0.62
+9%
|
0.68
+10%
|
0.67
-1%
|
0.67
N/A
|
0.73
+9%
|
0.75
+3%
|
0.77
+3%
|
0.79
+3%
|
0.81
+3%
|
0.78
-4%
|
0.78
N/A
|
0.85
+9%
|
0.86
+1%
|
0.93
+8%
|
1.05
+13%
|
1.11
+6%
|
1
-10%
|
0.98
-2%
|
1.01
+3%
|
1.09
+8%
|
1.11
+2%
|
1.38
+24%
|
1.44
+4%
|
1.28
-11%
|
1.28
N/A
|
1.26
-2%
|
1.19
-6%
|
1.21
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
